Circulating Intercellular Adhesion Molecule-1 in Patients with Lung Cancer.
-
- TAGUCHI Osamu
- The Third Department of Internal Medicine, Mie University School of Medicine
-
- GABAZZA Esteban Cesar
- The Third Department of Internal Medicine, Mie University School of Medicine
-
- KOBAYASHI Tetsu
- The Third Department of Internal Medicine, Mie University School of Medicine
-
- YOSHIDA Masamichi
- The Third Department of Internal Medicine, Mie University School of Medicine
-
- YASUI Hiroki
- The Third Department of Internal Medicine, Mie University School of Medicine
-
- KOBAYASHI Hiroyasu
- The Third Department of Internal Medicine, Mie University School of Medicine
書誌事項
- タイトル別名
-
- Circulating Intercellular Adhesion Mole
この論文をさがす
説明
Recently, abnormal expression of a great variety of adhesion molecules has been reported in malignancy. Of these adhesion molecules, intercellular adhesion molecule-1 (ICAM-1) has been suggested to play an important role in the process of tumor invasion and distant metastasis. The purpose of this investigation was to assess the peripheral blood levels of soluble ICAM-1 and the effect of cytotoxic therapy upon these circulating molecules in a cohort of patients with lung cancer. This study comprised 19 lung cancer patients hospitalized in our institution (males 16 and females 3, mean age 60 years old). Serum concentration of soluble ICAM-1 was measured using a commercially available enzyme immunoassay test kit. These measurements were done before the initiation of any therapy and on day 5 of chemotherapy. Samples taken from healthy volunteers were available for comparison. Soluble ICAM-1 serum concentration was significantly higher (p<0.0001) in the cancer patients as compared to that of the control group. Serum levels of ICAM1 were more significantly (p<0.02) elevated in patients with advanced stages of disease. This study suggests the presence of an increased expression of circulating adhesion molecules in lung cancer. The concentration of this adhesion molecule was correlated with the clinical stage of the malignant disease, but did not change significantly after multidrug cytotoxic therapy.<br>(Internal Medicine 36: 14-18, 1997)
収録刊行物
-
- Internal Medicine
-
Internal Medicine 36 (1), 14-18, 1997
一般社団法人 日本内科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204866092544
-
- NII論文ID
- 10008547991
-
- NII書誌ID
- AA10827774
-
- COI
- 1:STN:280:ByiB3M7gvFI%3D
-
- ISSN
- 13497235
- 09182918
-
- NDL書誌ID
- 4153803
-
- PubMed
- 9058094
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可